JAKARTA -- Indonesian pharmaceutical company Kalbe Farma is entering the clinical testing business with two Japanese companies to tap the country's growing demand for prevention of lifestyle-related diseases.
The foray marks a further diversification of Kalbe's business, which includes drugs, powdered milk and energy drinks. The company's pharmaceutical division, which accounts for about a quarter of total revenue, is facing pressure on margins as the government's universal healthcare program brings in more competition among drug makers.
